Early Phase Research Site Strategy Summit

On-Demand Content | Virtual Event

Dr. Stephanie Graff, MD, FACP joined as the Director of Breast Oncology at Lifespan Cancer Institute at Brown University in Providence, Rhode Island in the summer of 2021. Dr. Graff serves as co-lead of the Breast Cancer Translational Research Disease Working Group at Brown University and is an Assistant Professor of Medicine. Prior to joining the team at Lifespan/Brown, she was Director of both the Breast Program and Clinical Research at the Sarah Cannon Cancer Institute at HCA Midwest as well as Associate Director of the Breast Cancer Research Program at Sarah Cannon Research Institute and National Breast Lead for the Sarah Cannon Cancer Network’s clinical programs. In addition, Dr. Graff serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research.


Dr. Graff is board certified in Medical Oncology, Hematology, and Internal Medicine; and completed a breast oncology sub-fellowship at the University of Kansas. Dr. Graff has broad experience as a Principal Investigator on numerous clinical trials across all phases of drug development, in addition to work in translational research, genomics, and gender bias. In addition to scientific publications, she is an award-winning writer, social media influencer, and sought-after public speaker. Dr. Graff has received the Frist Humanitarian Award for her work in the community and currently serves on the American Cancer Society Rhode Island Leadership Council. Actively volunteering in the American Society of Clinical Oncology, she is a 2020 graduate of the prestigious ASCO Leadership Development Program, now serving on the Joint Certifications Committee and Women In Oncology Work Group. Ultimately, Dr. Graff is passionate about connecting with her patients to provide personalized, comprehensive oncology care, advancing breast cancer research, and breast cancer prevention.